Depression is common after AIDS-related central nervous system infections. Immunologic factors are involved in the development of depression, but few studies have evaluated CSF immune profiles.
We assessed risk factors for depression, defined by a Center for Epidemiological Studies-Depression (CES-D) score of >=16, among those with cryptococcal meningitis enrolled in two clinical trials in Kampala, Uganda from 2010-2014. We compared clinical factors and 19 CSF cytokines/chemokines (pg/mL) at screening with development and progression of depression at 4 and 12 weeks using descriptive statistics and t-tests.
186 participants with cryptococcal meningitis were screened for depression at 4 and/or 12 weeks. At 4 weeks, 75% of 146 were depressed versus 36% of 163 at 12 weeks. We grouped the 123 screened at both time points into those never depressed and those depressed at one/both time points. CSF opening pressure >25cm H2O was non-significantly higher in those never depressed (81% vs 57%, p=0.06), and closing pressure was significantly higher in those never depressed (11 vs 9cm H2O, p=.04). CSF macrophage activation marker sCD14 was significantly higher in those never depressed (median 634 vs 202 ng/mL, p=.045). CSF cytokines TNFa (14 vs 6 pg/mL; p=.06), IL-4 (1.9 vs 0.9; p=.06), and MCP1 (748 vs 315; p=.06) all trended towards significantly higher in those never depressed. CSF WBC and quantitative cultures did not differ between groups (P=.94; P=.29, respectively). We further separated groups into those never depressed, those who were depressed but improved, and those who worsened. Opening pressure >25cm was least frequent in the group that improved (81% vs. 47% vs, 88%, respectively; p=.03). Closing pressure was also lower in those who resolved their depression by 12 weeks (11 vs 8.8 vs 10.5cm, respectively; p=.03).
Half of those with cryptococcal meningitis who were depressed at 4 weeks had resolved their depression by 12 weeks. Intracranial pressure was highest in the groups of those never depressed and those who worsened between 4 and 12 weeks. It is possible the elevated pressure of those never depressed had appropriate inflammation, with elevated intracranial pressure while those who worsened had dysfunctional inflammation, which raised intracranial pressure and potential risk for depression. Depression was possibly associated with lower levels of CSF inflammation of the innate immune system: sCD14, TNFa, and MCP1 (CCL2) as well as Th2 IL-4 response.